Actively Recruiting
Modifying PEST for Psoriatic Arthritis Screening
Led by Novartis Pharmaceuticals · Updated on 2026-04-29
502
Participants Needed
21
Research Sites
83 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants with moderate-to-severe plaque PsO in Canada.
CONDITIONS
Official Title
Modifying PEST for Psoriatic Arthritis Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Moderate-to-severe plaque psoriasis patients who are candidates for biologic Disease-Modifying Antirheumatic Drugs (bDMARDs) as judged by their physician
- Adult patients at the time of signing informed consent
- Patients able to understand and willing to follow study instructions and requirements
- Residents of Canada
You will not qualify if you...
- Patients who previously screened positive for psoriatic arthritis using PEST
- Patients diagnosed with psoriatic arthritis
- Patients diagnosed with other inflammatory arthritis unrelated to psoriatic arthritis (rheumatoid arthritis, reactive arthritis, enteropathic arthritis, axial spondyloarthritis)
- Patients treated with bDMARDs for moderate-to-severe plaque psoriasis or any other condition within 6 months before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 21 locations
1
Novartis Investigative Site
Calgary, Alberta, Canada, T2J 7E1
Actively Recruiting
2
Novartis Investigative Site
Kelowna, British Columbia, Canada, V1W 4V5
Actively Recruiting
3
Novartis Investigative Site
Surrey, British Columbia, Canada, V3R 6A7
Actively Recruiting
4
Novartis Investigative Site
Winnipeg, Manitoba, Canada, R3C 0N2
Actively Recruiting
5
Novartis Investigative Site
Fredericton, New Brunswick, Canada, E3B 1G9
Actively Recruiting
6
Novartis Investigative Site
Hamilton, Ontario, Canada, L8J 0G5
Actively Recruiting
7
Novartis Investigative Site
Hamilton, Ontario, Canada, L8N 1V6
Actively Recruiting
8
Novartis Investigative Site
Hamilton, Ontario, Canada, L8P4B4
Actively Recruiting
9
Novartis Investigative Site
Markham, Ontario, Canada, L3R 2C7
Actively Recruiting
10
Novartis Investigative Site
North York, Ontario, Canada, M3B 3N1
Actively Recruiting
11
Novartis Investigative Site
Richmond Hill, Ontario, Canada, L4C 9M7
Actively Recruiting
12
Novartis Investigative Site
Stoney Creek, Ontario, Canada, L8G 1H1
Actively Recruiting
13
Novartis Investigative Site
Toronto, Ontario, Canada, M5S 1B6
Actively Recruiting
14
Novartis Investigative Site
Waterloo, Ontario, Canada, N2J 1C4
Actively Recruiting
15
Novartis Investigative Site
Montreal, Quebec, Canada, H1Y 3L1
Actively Recruiting
16
Novartis Investigative Site
Montreal, Quebec, Canada, H4A 3T2
Actively Recruiting
17
Novartis Investigative Site
Québec, Quebec, Canada, G1V 4X7
Actively Recruiting
18
Novartis Investigative Site
Ste-Foy, Quebec, Canada, G1V 4G2
Actively Recruiting
19
Novartis Investigative Site
Verdun, Quebec, Canada, H4G 3E7
Actively Recruiting
20
Novartis Investigative Site
Saskatoon, Saskatchewan, Canada, S7K 2C1
Actively Recruiting
21
Novartis Investigative Site
Saskatoon, Saskatchewan, Canada, S7K0H6
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here